Received Jun 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | 3046734 | IM |
chest pain; upper back pain; sore body; headache; chills; nausea; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pain), BACK PAIN (upper back pain), PAIN (sore body), HEADACHE (headache) and CHILLS (chills) in a 30-year-old female patient who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (batch no. 3046734) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 24-Jun-2025, the patient received dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use) .5 milliliter. On 25-Jun-2025, the patient experienced CHEST PAIN (chest pain), BACK PAIN (upper back pain), PAIN (sore body), HEADACHE (headache), CHILLS (chills) and NAUSEA (nausea). At the time of the report, CHEST PAIN (chest pain), BACK PAIN (upper back pain), PAIN (sore body), HEADACHE (headache), CHILLS (chills) and NAUSEA (nausea) had not resolved. The action taken with mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use) was unknown. No concomitant medication was reported. It was unknown if the patient experienced any additional symptoms/events. No treatment medication was reported.